I'm not here to cross promote, but to give you some assistance.
As someone who has owned both AVH and TIS, I would strongly suggest you look at the ZACKS broker report (3 days old)which can be found on the 'in the news' section on Avita's website.
That will give you a better understanding of the single treatment process of ReCell and related costs.
TIS holders have been let down by management trying to take the easy road to commercialisation and I feel for them.
Hopefully, the reclassification issue gets sorted very soon.
TIS Price at posting:
11.9¢ Sentiment: LT Buy Disclosure: Not Held